GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
3B2U | P00533 | Crystal structure of isolated domain III of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8 | |
3B2V | P00533 | Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8 | |
3C09 | P00533 | Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the extracellular region of EGFR | |
3NJP | P00533 | The Extracellular and Transmembrane Domain Interfaces in Epidermal Growth Factor Receptor Signaling | |
3P0Y | P00533 | anti-EGFR/HER3 Fab DL11 in complex with domain III of EGFR extracellular region | Epidermal growth factor receptor(E.C.2.7.10.1), Fab DL11 heavy chain, Fab DL11 light chain |
3QWQ | P00533 | Crystal structure of the extracellular domain of the epidermal growth factor receptor in complex with an adnectin | |
4KRL | P00533 | Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 6.0 | |
4KRM | P00533 | Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 3.5 | |
4KRO | P00533 | Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR | |
4KRP | P00533 | Nanobody/VHH domain 9G8 in complex with the extracellular region of EGFR | |
4UIP | P00533 | The complex structure of extracellular domain of EGFR with Repebody (rAC1). | |
4UV7 | P00533 | The complex structure of extracellular domain of EGFR and GC1118A | |
8HGS | P00533 | The EGF-bound EGFR ectodomain homodimer | |
7LEN | P00533 | Crystal structure of the epidermal growth factor receptor extracellular region with R84K mutation in complex with epiregulin crystallized with trehalose | |
7LFS | P00533 | Crystal structure of the epidermal growth factor receptor extracellular region with A265V mutation in complex with epiregulin | |
7OM4 | P00533 | Nanobody EgB4 bound to the full extracellular EGFR-EGF complex | |
8HGO | P00533 | The EGF-bound EGFR/HER2 ectodomain complex | |
8HGP | P00533 | The EREG-bound EGFR/HER2 ectodomain complex | |
8UKW | P00533 | Crystal structure the extracellular region of the epidermal growth factor receptor variant III (EGFRvIII) at pH 5.0 | |
8UKX | P00533 | Crystal structure the extracellular region of the epidermal growth factor receptor variant III (EGFRvIII) at pH 7.0 | |
6XX2 | P00523 | Crystal structure of the c-Src SH3 domain H122R-Q128K mutant in complex with Cu(II) at pH 7.5 co-crystallized with methyl beta-cyclodextrin | |
6XX3 | P00523 | Crystal structure of the c-Src SH3 domain H122R-Q128E mutant in complex with Cu(II) at pH 6.5 co-crystallized with methyl beta-cyclodextrin | |
6XX4 | P00523 | Crystal structure of the c-Src SH3 domain H122R-Q128E mutant in complex with Ni(II) at pH 7.5 co-crystallized with methyl beta-cyclodextrin | |
6XX5 | P00523 | Crystal structure of the c-Src SH3 domain H122R-Q128K mutant in complex with Ni(II) at pH 7.5 co-crystallized with methyl beta-cyclodextrin | |
1MTO | P00512 | Crystal structure of a Phosphofructokinase mutant from Bacillus stearothermophilus bound with fructose-6-phosphate | |
4PFK | P00512 | PHOSPHOFRUCTOKINASE. STRUCTURE AND CONTROL | |
1D6N | P00492 | TERNARY COMPLEX STRUCTURE OF HUMAN HGPRTASE, PRPP, MG2+, AND THE INHIBITOR HPP REVEALS THE INVOLVEMENT OF THE FLEXIBLE LOOP IN SUBSTRATE BINDING | |
1AHP | P00490 | OLIGOSACCHARIDE SUBSTRATE BINDING IN ESCHERICHIA COLI MALTODEXTRIN PHSPHORYLASE | |
1E4O | P00490 | Phosphorylase recognition and phosphorolysis of its oligosaccharide substrate: answers to a long outstanding question | MALTODEXTRIN PHOSPHORYLASE (E.C.2.4.1.1) |
1L5V | P00490 | Crystal Structure of the Maltodextrin Phosphorylase complexed with Glucose-1-phosphate | |
1QM5 | P00490 | Phosphorylase recognition and phosphorylysis of its oligosaccharide substrate: answers to a long outstanding question | |
2ASV | P00490 | X-Ray studies on protein complexes: Enzymatic catalysis in Crystals of E. coli Maltodextrin Phosphorylase (MalP) | |
2AV6 | P00490 | X-Ray studies on maltodextrin phosphorylase complexes: recognition of substrates and cathalitic mechanism of phosphorylase family | |
2AW3 | P00490 | X-Ray studies on maltodextrin phosphorylase complexes: recognition of substrates and cathalitic mechanism of phosphorylase family | |
2AZD | P00490 | X-Ray studies on Maltodextrin Phosphorylase (MalP) Complexes: recognition of substrates and CATALYTIC mechanism of phosphorylase family | |
2ECP | P00490 | THE CRYSTAL STRUCTURE OF THE E. COLI MALTODEXTRIN PHOSPHORYLASE COMPLEX | MALTODEXTRIN PHOSPHORYLASE, PYRIDOXAL-5'-PHOSPHATE |
1A8I | P00489 | SPIROHYDANTOIN INHIBITOR OF GLYCOGEN PHOSPHORYLASE | |
1B4D | P00489 | AMIDOCARBAMATE INHIBITOR OF GLYCOGEN PHOSPHORYLASE | |
6GPB | P00489 | REFINED CRYSTAL STRUCTURE OF THE PHOSPHORYLASE-HEPTULOSE 2-PHOSPHATE-OLIGOSACCHARIDE-AMP COMPLEX | GLYCOGEN PHOSPHORYLASE B (E.C.2.4.1.1) (T STATE) COMPLEX WITH HEPTULOSE 2-PHOSPHATE AND MALTOHEPTAOSE AND AMP |
1E1Y | P00489 | Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site | GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (E.C.2.4.1.1) |
1FS4 | P00489 | Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design | GLYCOGEN PHOSPHORYLASE (E.C.2.4.1.1) |
1FTQ | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FTW | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FTY | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FU4 | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FU7 | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FU8 | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1GG8 | P00489 | DESIGN OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE: A STUDY OF ALPHA-AND BETA-C-GLUCOSIDES AND 1-THIO-BETA-D-GLUCOSE COMPOUNDS | |
1GGN | P00489 | Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design | |
1GPY | P00489 | CRYSTALLOGRAPHIC BINDING STUDIES ON THE ALLOSTERIC INHIBITOR GLUCOSE-6-PHOSPHATE TO T STATE GLYCOGEN PHOSPHORYLASE B | GLYCOGEN PHOSPHORYLASE B (E.C.2.4.1.1) (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE-6-PHOSPHATE |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024